| Product Code: ETC12011566 | Publication Date: Apr 2025 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Drug Repurposing Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Drug Repurposing Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Drug Repurposing Market - Industry Life Cycle |
3.4 Taiwan Drug Repurposing Market - Porter's Five Forces |
3.5 Taiwan Drug Repurposing Market Revenues & Volume Share, By Approach, 2021 & 2031F |
3.6 Taiwan Drug Repurposing Market Revenues & Volume Share, By Disease Area, 2021 & 2031F |
3.7 Taiwan Drug Repurposing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Taiwan Drug Repurposing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Taiwan Drug Repurposing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Taiwan Drug Repurposing Market Trends |
6 Taiwan Drug Repurposing Market, By Types |
6.1 Taiwan Drug Repurposing Market, By Approach |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Drug Repurposing Market Revenues & Volume, By Approach, 2021 - 2031F |
6.1.3 Taiwan Drug Repurposing Market Revenues & Volume, By On-Target Repurposing, 2021 - 2031F |
6.1.4 Taiwan Drug Repurposing Market Revenues & Volume, By Off-Target Repurposing, 2021 - 2031F |
6.1.5 Taiwan Drug Repurposing Market Revenues & Volume, By Combination Drug Repurposing, 2021 - 2031F |
6.1.6 Taiwan Drug Repurposing Market Revenues & Volume, By Pathway-Based Repurposing, 2021 - 2031F |
6.2 Taiwan Drug Repurposing Market, By Disease Area |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Drug Repurposing Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.2.3 Taiwan Drug Repurposing Market Revenues & Volume, By Neurodegenerative Diseases, 2021 - 2031F |
6.2.4 Taiwan Drug Repurposing Market Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031F |
6.2.5 Taiwan Drug Repurposing Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
6.3 Taiwan Drug Repurposing Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Drug Repurposing Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.3 Taiwan Drug Repurposing Market Revenues & Volume, By Biotechnology Firms, 2021 - 2031F |
6.3.4 Taiwan Drug Repurposing Market Revenues & Volume, By Academic Research Institutes, 2021 - 2031F |
6.3.5 Taiwan Drug Repurposing Market Revenues & Volume, By Contract Research Organizations (CROs), 2021 - 2031F |
6.4 Taiwan Drug Repurposing Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 Taiwan Drug Repurposing Market Revenues & Volume, By Computational Drug Repurposing, 2021 - 2031F |
6.4.3 Taiwan Drug Repurposing Market Revenues & Volume, By High-Throughput Screening, 2021 - 2031F |
6.4.4 Taiwan Drug Repurposing Market Revenues & Volume, By Biomarker-Based Repurposing, 2021 - 2031F |
6.4.5 Taiwan Drug Repurposing Market Revenues & Volume, By AI & Machine Learning in Drug Repurposing, 2021 - 2031F |
7 Taiwan Drug Repurposing Market Import-Export Trade Statistics |
7.1 Taiwan Drug Repurposing Market Export to Major Countries |
7.2 Taiwan Drug Repurposing Market Imports from Major Countries |
8 Taiwan Drug Repurposing Market Key Performance Indicators |
9 Taiwan Drug Repurposing Market - Opportunity Assessment |
9.1 Taiwan Drug Repurposing Market Opportunity Assessment, By Approach, 2021 & 2031F |
9.2 Taiwan Drug Repurposing Market Opportunity Assessment, By Disease Area, 2021 & 2031F |
9.3 Taiwan Drug Repurposing Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Taiwan Drug Repurposing Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Taiwan Drug Repurposing Market - Competitive Landscape |
10.1 Taiwan Drug Repurposing Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Drug Repurposing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here